digital currency in india in hindi- Top People searches

China's assets ETF and China Stock Exchange rose by nearly 5% when they were rich, China's assets ETF and China Stock Exchange rose by nearly 5% when they were rich, and China's ETF rose by nearly 5% when they were rich three times. China's overseas Internet ETF rose by nearly 2%; Bili Bili rose nearly 4%, Xpeng Motors rose nearly 3%, Pinduoduo and Baidu rose over 2%, and Ali and Weilai rose nearly 2%.Binhua Co., Ltd. set up a new equipment technology company in Shandong. According to the enterprise search APP, Shandong Hualu Dingcheng Equipment Technology Co., Ltd. was established recently. The legal representative is Dong Hongbo, with a registered capital of 10 million yuan. Its business scope includes: cloud computing equipment technical services; Intelligent basic manufacturing equipment manufacturing; Intelligent basic manufacturing equipment sales. Enterprise equity penetration shows that the company is wholly owned by Binhua shares.Zuckerberg is reported to have donated $1 million to Trump's inauguration fund.

In the concept of ice and snow economy, there were many daily limit changes, such as iceberg cold and hot, iceberg cold and hot, Longjian shares and Jingxue energy-saving daily limit, and Dalian Shengya, Changbai Mountain, Yeti shares and Sante ropeway were among the top gainers.Wei Lanfeng became the vice president and chief operating officer of Porsche China, and Porsche announced that Philipp von Witzendorff will officially become the vice president and chief operating officer of Porsche China from January 1st, 2025. It is understood that in the past two years, Wei Lanfeng has served as President and CEO of Porsche Japan.CICC and others set up a venture capital partnership in Xiamen. According to the enterprise search APP, Zhongjin Qiyuan Phase II (Xiamen) Venture Capital Partnership (Limited Partnership) was recently established with a capital contribution of 400 million yuan. Its business scope includes: engaging in equity investment, investment management, asset management and other activities with private equity funds. Enterprise investigation shows that the company is jointly held by CICC Capital Operation Co., Ltd., a wholly-owned subsidiary of CICC.

Wang Xiaochuan Baichuan Intelligent has set up a technology company in Ningbo with a number of AI businesses. According to enterprise investigation, recently, Ningbo Baichuan Ronghui Technology Co., Ltd. was established with Wang Xiaochuan as the legal representative and a registered capital of 70 million US dollars. Its business scope includes artificial intelligence dual-creation service platform, artificial intelligence theory and algorithm software development, artificial intelligence basic software development, artificial intelligence general application system, artificial intelligence public data platform and artificial intelligence public service platform technical consulting service. Equity penetration shows that the company is wholly owned by BAICHUAN AI (HK) LIMITED.OpenAI：Sora has started partial recovery, and OpenAI updated the outage accident report, saying that remedial work is continuing. API traffic recovery is in progress, and we are recovering ChatGPT traffic by region. Sora has begun a partial recovery.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.